Chronic immune activation underlies morbid obesity: Is IDO a key player?

Current Drug Metabolism

Volumn 8, Issue 3, 2007, Pages 289-295

  Brandacher, G ^a   Hoeller, E ^a   Fuchs, D ^a,b   Weiss, Helmut G ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Chronic immune activation; Indoleamine2,3 dioxygenase; Morbid obesity; Serotonin

Indexed keywords

FENFLURAMINE; FLUOXETINE; GAMMA INTERFERON; GHRELIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1; INTERLEUKIN 6; KYNURENINE; LEPTIN; NALOXONE; NEOPTERIN; NICOTINIC ACID; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ADDICTION; ADIPOSE TISSUE; AMINO ACID BLOOD LEVEL; BARIATRIC SURGERY; CALORIC INTAKE; CELL TYPE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; DIETARY INTAKE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; FOOD INTAKE; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; MACROPHAGE; MOOD DISORDER; MORBID OBESITY; NONHUMAN; PATHOGENESIS; REVIEW; SATIETY; SEROTONIN RELEASE; TRYPTOPHAN METABOLISM; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; BARIATRIC SURGERY; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LEPTIN; MACROPHAGES; OBESITY, MORBID; PEPTIDE HORMONES; SEROTONIN; SUBSTANCE-RELATED DISORDERS; TRYPTOPHAN; WEIGHT LOSS;

EID: 34247180292     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920007780362590     Document Type: Review

References (74)

1. Cancer Facts and Figures 2002. American Cancer Society. Surveillance Research pp. 1-27.
2. Hu, F.B., Willett, W.C., Li, T., Stampfer, M.J., Colditz, G.A. and Manson, J.E. (2004) N. Engl. J. Med. 351, 2694-2703.
3. Fontaine, K.R., Redden, D.T., Wang, C., Westfall, A.O. and Allison, D.B. (2003) JAMA 289, 187-193.
4. Calle, E.E., Thun, M.J., Petrelli, J.M., Rodriguez, C. and Heath, C.W. Jr. (1999) N. Engl. J. Med. 341, 1097-1105.
5. Cikim, A.S., Ozbey, N. and Orhan, Y. (2004) J. Int. Med. Res. 32, 268-273.
6. Cottam, D.R., Mattar, S.G., Barinas-Mitchell, E., Eid, G., Kuller, L., Kelley, D.E. and Schauer, P.R. (2004) Obes. Surg. 14, 589-600.
7. Koenig, W., Sund, M., Frohlich, M., Fischer, H.G., Lowel, H., Doring, A., Hutchinson, W.L. and Pepys, M.B. (1999) Circulation, 99, 237-242.
8. Hotamisligil, G.S. (1999) J. Intern. Med., 245, 621-625.
9. Zahorska-Markiewicz, B., Janowska, J., Olszanecka-Glinianowicz, M. and Zurakowski, A. (2000) Int. J. Obes. Relat. Metab. Disord. 24, 1392-1395.
10. Bastard, J.P., Jardel, C., Delattre, J., Hainque, B., Bruckert, E. and Oberlin, F. (1999) Circulation 99, 2221-2222.
11. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A. and Chen, H. (2003) J. Clin. Invest. 112, 1821-1830.
12. La Cava, A., Matarese, G. (2004) Nat. Rev. Immunol. 4, 371-379.
13. Ramos, E.J., Xu, Y., Romanova, I., Middleton, F., Chen, C., Quinn, R., Inui, A., Das, U. and Meguid, M.M. (2003) Surgery 134, 329-335.
14. Toni, R., Malaguti, A., Castorina, S., Roti, E. and Lechan, R.M. (2004) J. Endocrinol. Invest. 27, 182-186.
15. Cancello, R. and Clement, K. (2006) B.J.O.G. 113, 1141-1147.
16. Ledochowski, M., Murr, C., Widner, B. and Fuchs, D. (1999) Clin. Chim. Acta 282, 115-123.
17. Schennach, H., Lanthaler, A.J., Mayersbach, P., Ulmer, H., Muell, K., Schoenitzer, D., Fuchs, D. and Larcher, C. (2002) J. Infect. Dis. 186, 1494-1497.
18. Huang, A., Fuchs, D., Widner, B., Glover, C., Henderson, D.C. and Allen-Mersh, T.G. (2002) Br. J. Cancer 86, 1691-1696.
19. Murr, C., Fuith, L.C., Widner, B., Wirleitner, B., Baier-Bitterlich, G. and Fuchs, D. (1999) Anticancer Res. 19, 1721-1728.
20. Schroecksnadel, K., Kaser, S., Ledochowski, M., Neurauter, G., Mur, E., Herold, M. and Fuchs, D. (2003) J. Rheumatol. 30, 1935-1939.
21. Reibnegger, G., Aichberger, C., Fuchs, D., Hausen, A., Spielberger, M., Werner, E.R., Margreiter, R. and Wachtehr, H. (1991) Transplantation 52, 58-63.
22. Murr, C., Widner, B., Wirleitner, B. and Fuchs, D. (2002) Curr. Drug Metab. 3, 175-187.
23. Mellor, A.L. and Munn, D.H. (2003) J. Immunol. 170, 5809-5813.
24. Taylor, M.W. and Feng, G.S. (1991) FASEB J. 5, 2516-2522.
25. Mertens, A., Verhamme, P., Bielicki, J.K., Phillips, M.C., Quarck, R., Verreth, W., Stengel, D., Ninio, E., Navab, M., Mackness, B., Mackness, M. and Holvoet, P. (2003) Circulation 107, 1640-1646.
26. Fuchs, D., Moller, A.A., Reibnegger, G., Werner, E.R., Werner-Felmayer, G., Dierich, M.P. and Wachter, H. (1991) Immunol. Lett. 28, 207-211.
27. Zhang, H.H., Halbleib, M., Ahmad, F., Manganiello, V.C. and Greenberg, A.S. (2002) Diabetes 51, 2929-2935.
28. Nonogaki, K., Fuller, G.M., Fuentes, N.L., Moser, A.H., Staprans, I., Grunfeld, C. and Feingold, K.R. (1995) Endocrinology 136, 2143-2149.
29. Fuchs, D., Moller, A.A., Reibnegger, G., Werner, E.R., Werner-Felmayer, G., Dierich, M.P. and Wachter, H. (1991) Immunol. Lett. 28, 207-211.
30. Mellor, A.L. and Munn, D.H. (2003) J. Immunol. 170, 5809-5813.
31. Taylor, M.W. and Feng, G.S. (1991) FASEB J. 5, 2516-2522.
32. Uyttenhove, C., Pilotte, L., Theate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T. and Van den Eynde, B.J. (2003) Nat. Med. 9, 1269-1274.
33. Mellor, A.L., Keskin, D.B., Johnson, T., Chandler, P. and Munn, D.H. (2002) J. Immunol. 168, 3771-3776.
34. Lawton, C.L., Wales, J.K., Hill, A.J. and Blundell, J.E. (1995) Obes. Res. 3, 345-356.
35. Halford, J.C. and Blundell, J.E. (2000) Ann. Med. 32, 222-232.
36. Wurtman, R.J. and Wurtman, J.J. (1995) Obes. Res. 3, 477S-480S.
37. Blundell, J.E. and Lawton, C.L. (1995) Metabolism 44, 33-37.
38. Bray, G.A. (2001) Rev. Endocr. Metab. Disord. 2, 403-418.
39. Hagan, M.M., Holguin, F.D., Cabello, C.E., Hanscom, D.R. and Moss, D.E. (1997) Pharmacol. Biochem. Behav. 58, 1103-1107.
40. Buwalda, B., Blom, W.A., Koolhaas, J.M. and van Dijk, G. (2001) Physiol. Behav. 73, 371-377.
41. Cavaliere, H. and Medeiros-Neto, G. (1997) Eat Weight Disord. 2, 211-215.
42. Moreno, F.A., McGavin, C., Malan, T.P., Gelenberg, A.J., Heninger, G.R., Mathe, A.A. and Delgado, P.L. (2000) Int. J. Neuropsychopharmacol. 3, 277-283.
43. Caballero, B., Finer, N. and Wurtman, R.J. (1988) Metabolism 37, 672-676.
44. Ashley, D.V., Fleury, M.O., Golay, A., Maeder, E. and Leathwood, P.D. (1985) Am. J. Clin. Nutr. 42, 1240-1245.
45. Murray, M.F. (2003) Lancet Infect. Dis. 3, 644-652.
46. Brown, R.R. (1996) Adv. Exp. Med. Biol. 398, 15-25.
47. Brandacher, G., Winkler, C., Aigner, F., Schwelberger, H., Schroecksnadel, K., Margreiter, R., Fuchs, D. and Weiss, H.G. (2006) Obes. Surg. 16, 541-548.
48. Weight cycling: National Task Force on the Prevention and Treatment of Obesity. (1994) JAMA 272, 1196-1202.
49. Cabeza de Vaca, S. and Carr, K.D. (1998) J. Neurosci. 18, 7502-7510.
50. Carr, K.D. (2002) Physiol. Behav. 76, 353-364.
51. Colantuoni, C., Rada, P., McCarthy, J., Patten, C., Avena, N.M., Chadeayne, A. and Hoebel, B.G. (2002) Obes. Res. 10, 478-488.
52. Hagan, M.M., Chandler, P.C., Wauford, P.K., Rybak, R.J. and Oswald, K.D. (2003) Int. J. Eat. Disord. 34, 183-197.
53. Soderpalm, A.H. and Hansen, S. (1999) Physiol. Behav. 67, 409-415.
54. Turek, F.W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G., McDearmon, E., Laposky, A., Losee-Olson, S., Easton, A., Jensen, D.R., Eckel, R.H., Takahashi, J.S. and Bass, J. (2005) Science 308, 1043-1045.
55. Uz, T., Ahmed, R., Akhisaroglu, M., Kurtuncu, M., Imbesi, M., Dirim Arslan, A. and Manev, H. (2005) Neuroscience 134, 1309-1316.
56. Mason, E.E. (1982) Arch. Surg. 117, 701-706.
57. Kuzmak, L.I., Yap, I.S., McGuire, L., Dixon, J.S. and Young, M.P. (1990) AORN J. 51, 1307-1324.
58. Mason, E.E. and Ito, C. (1969) Ann. Surg. 170, 329-339.
59. Scopinaro, N., Gianetta, E., Civalleri, D., Bonalumi, U. and Bachi, V. (1979) Br. J. Surg. 66, 618-620.
60. Andersen, T., Backer, O.G., Stokholm, K.H. and Quaade, F. (1984) N. Engl. J. Med. 310, 352-356.
61. Sjostrom, L., Lindroos, A.K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjostrom, C.D., Sullivan, M., Wedel, H.; Swedish Obese Subjects Study Scientific Group. (2004) N. Engl. J. Med. 351, 2683-2693.
62. Ryden, A., Sullivan, M., Torgerson, J.S., Karlsson, J., Lindroos, A.K. and Taft, C. A. (2004) Int. J. Obes. Relat. Metab. Disord. 28, 1485-1493.
63. Weiss, H.G., Nehoda, H., Labeck, B., Peer-Kuehberger, R., Oberwalder, M., Aigner, F. and Wetscher, G.J. (2002) Obes. Surg. 12, 573-578.
64. Laimer, M., Ebenbichler, C.F., Kaser, S., Sandhofer, A., Weiss, H., Nehoda, H., Aigner, F. and Patsch, J.R. (2002) Int. J. Obes. Relat. Metab. Disord. 26, 659-662.
65. Cikim, A.S., Ozbey, N. and Orhan, Y. (2004) J. Int. Med. Res. 32, 268-273.
66. Pacifico, L., Di Renzo, L., Anania, C., Osborn, J.F., Ippoliti, F., Schiavo, E. and Chiesa, C. (2006) Eur. J. Endocrinol. 154, 691-697.
67. Farooqi, I.S., Matarese, G., Lord, G.M., Keogh, J.M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S.A., Perna, F., Fontana, S., Lechler, R.I., DePaoli, A.M. and O'Rahilly, S. (2002) J. Clin. Invest. 110, 1093-1103.
68. Dixit, V.D., Schaffer, E.M., Pyle, R.S., Collins, G.D., Sakthivel, S.K., Palaniappan, R., Lillard, J.W. Jr. and Taub, D.D. (2004) J. Clin. Invest. 114, 57-66.
69. Mito, N., Hosoda, T., Kato, C. and Sato, K. (2000) Metabolism 49, 1295-1300.
70. Nieman, D.C., Henson, D.A., Nehlsen-Cannarella, S.L., Ekkens, M., Utter, A.C., Butterworth, D.E. and Fagoaga, O.R. (1999) J. Am. Diet. Assoc. 99, 294-299.
71. Lord, G.M., Matarese, G., Howard, J.K., Baker, R.J., Bloom, S.R. and Lechler, R.I. (1998) Nature 394, 897-901.
72. Verwaerde, C., Delanoye, A., Macia, L, Tailleux, A. and Wolowczuk, I. (2006) Scand. J. Immunol. 64, 457-466.
73. Visser, M., Bouter, L.M., McQuillan, G.M., Wener, M.H. and Harris, T.B. (2001) Pediatrics 107, E13.
74. Weiss, R., Dziura, J., Burgert, T.S., Tamborlane, W.V., Taksali, S.E., Yeckel, C.W., Allen, K., Lopes, M., Savoye, M., Morrison, J., Sherwin, R.S. and Caprio, S. (2004) N. Engl. J. Med. 350, 2362-2374.